Philippe Van Wilder

530 total citations
28 papers, 357 citations indexed

About

Philippe Van Wilder is a scholar working on Economics and Econometrics, Immunology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Philippe Van Wilder has authored 28 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Economics and Econometrics, 7 papers in Immunology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Philippe Van Wilder's work include Health Systems, Economic Evaluations, Quality of Life (22 papers), Pharmaceutical Economics and Policy (9 papers) and Pharmaceutical studies and practices (6 papers). Philippe Van Wilder is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (22 papers), Pharmaceutical Economics and Policy (9 papers) and Pharmaceutical studies and practices (6 papers). Philippe Van Wilder collaborates with scholars based in Belgium, Netherlands and United States. Philippe Van Wilder's co-authors include Steven Simoens, Irina Cleemput, Arnold G. Vulto, Isabelle Huys, France Vrijens, Irina Odnoletkova, Esther de Vries, Gerhard Kindle, Kris Bogaerts and Stephan Ehl and has published in prestigious journals such as PLoS ONE, Frontiers in Pharmacology and BMC Health Services Research.

In The Last Decade

Philippe Van Wilder

27 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Van Wilder Belgium 10 182 143 56 51 39 28 357
Scott Bowen United States 9 97 0.5× 29 0.2× 170 3.0× 47 0.9× 36 0.9× 13 341
J.M. Hernánz Spain 13 249 1.4× 74 0.5× 17 0.3× 32 0.6× 78 2.0× 28 445
Gregory Mears United States 11 269 1.5× 18 0.1× 40 0.7× 59 1.2× 29 0.7× 14 642
Michael Hurley United States 10 80 0.4× 23 0.2× 21 0.4× 35 0.7× 71 1.8× 18 451
Tobias Weberschock Germany 13 137 0.8× 23 0.2× 11 0.2× 20 0.4× 69 1.8× 22 461
J.L. Sánchez‐Carazo Spain 14 268 1.5× 94 0.7× 28 0.5× 8 0.2× 108 2.8× 38 470
Jason Pradarelli United States 7 78 0.4× 36 0.3× 134 2.4× 32 0.6× 51 1.3× 10 406
Simona Radice Italy 10 140 0.8× 50 0.3× 136 2.4× 13 0.3× 82 2.1× 22 374
Paul M. Ossenkoppele Netherlands 10 316 1.7× 89 0.6× 14 0.3× 5 0.1× 85 2.2× 14 441
Joshua C. Pritchett United States 13 83 0.5× 25 0.2× 12 0.2× 17 0.3× 225 5.8× 39 479

Countries citing papers authored by Philippe Van Wilder

Since Specialization
Citations

This map shows the geographic impact of Philippe Van Wilder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Van Wilder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Van Wilder more than expected).

Fields of papers citing papers by Philippe Van Wilder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Van Wilder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Van Wilder. The network helps show where Philippe Van Wilder may publish in the future.

Co-authorship network of co-authors of Philippe Van Wilder

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Van Wilder. A scholar is included among the top collaborators of Philippe Van Wilder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Van Wilder. Philippe Van Wilder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Simoens, Steven, et al.. (2023). The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis. Health Research Policy and Systems. 21(1). 68–68. 5 indexed citations
3.
4.
Simoens, Steven, et al.. (2022). Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study. BMC Health Services Research. 22(1). 1211–1211. 4 indexed citations
5.
Simoens, Steven, et al.. (2021). Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis. Frontiers in Pharmacology. 12. 644187–644187. 18 indexed citations
6.
Annemans, Lieven, Philippe Beutels, David E. Bloom, et al.. (2020). Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective. Value in Health. 24(1). 105–111. 25 indexed citations
7.
Wilder, Philippe Van, et al.. (2019). Benchmarking de la prothèse hanche dans 7 hôpitaux. N°5(5). 410–410. 1 indexed citations
8.
Wilder, Philippe Van, Michael Pirson, & Alain Dupont. (2019). Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium. European Journal of Clinical Pharmacology. 75(7). 895–900. 2 indexed citations
9.
Wilder, Philippe Van, et al.. (2018). Evaluation of cost and length of stay’s homogeneity per APR-DRG for oncological inpatient stays in 11 Belgian hospitals. Vol. 36(4). 217–233. 1 indexed citations
10.
Wilder, Philippe Van, et al.. (2018). The hospital cost of hip replacement for old inpatients in Belgium. European Geriatric Medicine. 10(1). 67–78. 1 indexed citations
11.
Odnoletkova, Irina, Gerhard Kindle, Isabella Quinti, et al.. (2018). The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet Journal of Rare Diseases. 13(1). 201–201. 113 indexed citations
12.
Wilder, Philippe Van. (2012). Advanced Therapy Medicinal Products and Exemptions to the Regulation 1394/2007: How Confident Can We be? An Exploratory Analysis. Frontiers in Pharmacology. 3. 12–12. 25 indexed citations
13.
Cleemput, Irina & Philippe Van Wilder. (2009). History of health technology assessment in Belgium. International Journal of Technology Assessment in Health Care. 25(S1). 82–87. 7 indexed citations
14.
Cleemput, Irina, et al.. (2008). Recommandations pour les évaluations pharmacoéconomiques en Belgique. 4 indexed citations
15.
Cleemput, Irina, et al.. (2008). Guidelines for Pharmacoeconomic Evaluations in Belgium. 18 indexed citations
16.
Cleemput, Irina, et al.. (2008). Richtlijnen voor farmaco-economische evaluaties in België. 3 indexed citations
17.
Wilder, Philippe Van & Alain Dupont. (2008). Introducing Evidence-Based Medicine in Reimbursement Procedures: Does It Affect the Outcome?. Value in Health. 11(4). 784–787. 9 indexed citations
18.
Cleemput, Irina, et al.. (2008). Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests. Value in Health. 12(4). 441–449. 31 indexed citations
19.
20.
Cleemput, Irina, et al.. (2006). Voorlopige richtlijnen voor farmaco-economisch onderzoek in België. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott Bowen Breakdown of academic impact, for papers by J.M. Hernánz Breakdown of academic impact, for papers by Gregory Mears Breakdown of academic impact, for papers by Michael Hurley Breakdown of academic impact, for papers by Tobias Weberschock Breakdown of academic impact, for papers by J.L. Sánchez‐Carazo Breakdown of academic impact, for papers by Jason Pradarelli Breakdown of academic impact, for papers by Simona Radice Breakdown of academic impact, for papers by Paul M. Ossenkoppele Breakdown of academic impact, for papers by Joshua C. Pritchett
Rankless by CCL
2026